Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-16,640
Closed -$695K 403
2017
Q2
$695K Buy
16,640
+1,360
+9% +$67.8K 0.01% 303
2017
Q1
$796K Buy
15,280
+1,640
+12% +$93K 0.01% 279
2016
Q4
$780K Buy
13,640
+1,855
+16% +$107K 0.01% 270
2016
Q3
$721K Sell
11,785
-4,460
-27% -$270K 0.01% 277
2016
Q2
$1.03M Buy
16,245
+1,160
+8% +$76.7K 0.01% 223
2016
Q1
$1.08M Buy
15,085
+125
+0.8% +$8.27K 0.01% 217
2015
Q4
$990K Buy
14,960
+1,076
+8% +$76.6K 0.01% 234
2015
Q3
$938K Buy
13,884
+1,999
+17% +$128K 0.01% 232
2015
Q2
$739K Buy
11,885
+620
+6% +$38.7K 0.01% 269
2015
Q1
$733K Buy
11,265
+2,765
+33% +$169K 0.01% 252
2014
Q4
$492K Buy
8,500
+140
+2% +$7.46K 0.01% 297
2014
Q3
$405K Sell
8,360
-1,700
-17% -$87.4K 0.01% 312
2014
Q2
$535K Hold
10,060
0.01% 270
2014
Q1
$572K Buy
10,060
+383
+4% +$21.9K 0.01% 260
2013
Q4
$545K Buy
9,677
+685
+8% +$33.8K 0.01% 252
2013
Q3
$417K Sell
8,992
-230
-2% -$10.5K 0.01% 271
2013
Q2
$443K Buy
+9,222
New +$406K 0.01% 249

Other funds holding MNRO

Bahl & Gaynor's MNRO Position: Q3 2017 in Review

Bahl & Gaynor sold out of Monro (MNRO) in Q3 2017, closing a stake of 16,640 shares — an estimated $695K sold.

Bahl & Gaynor first reported a position in MNRO in Q2 2013 and held it in 17 quarters. The position peaked at $1.08M in Q1 2016. 190 funds tracked by Wall St. Rank hold MNRO as of Q3 2017.

  • Bahl & Gaynor reported no remaining Monro position as of Q3 2017 after selling out during the quarter.
  • Bahl & Gaynor sold 16,640 Monro shares in Q3 2017, an estimated $695K.
  • Bahl & Gaynor first reported a position in Monro in Q2 2013 and held it in 17 quarters.
  • Bahl & Gaynor's Monro position peaked at $1.08M in Q1 2016.
  • 190 funds tracked by Wall St. Rank held Monro as of Q3 2017.

Based on Bahl & Gaynor's 13F filing for Q3 2017, filed 13 Nov 2017.